- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01911481
Maternal Oral Hydration and External Cephalic Version
December 9, 2015 updated by: University of Milano Bicocca
Maternal Oral Hydration and External Cephalic Version: a Single Blind Randomised Controlled Trial
The investigators are carrying out a study of 164 pregnant women, with breech presentation at term who will undergo to external cephalic version.
The investigators' goal is to know if oral maternal hydration can increase the successful of external cephalic version
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
164
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Monza Brianza
-
Monza, Monza Brianza, Italy, 20900
- San Gerardo Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- single gestation
- breech presentation
- from 37 to 41,5 weeks
- without pregnancy complications
- fetus adequate for gestational age
- without fetal malformations
- intact membranes
- amniotic fluid index between 7 and 24 cm
- placenta properly inserted
Exclusion Criteria:
- age less than 18 years
- maternal disease at risk of fluid overload (cardiac disease, renal impairment, moderate or severe preeclampsia or hypertension and diabetes)
- contraindications for vaginal birth
- vaginal blood loss
- uterine contractions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control
|
|
|
Experimental: hydration
after recruitment the women in hydration group will be invited to drink 2 litres of water,in 2 hours
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with external cephalic version successful after maternal oral hydration
Time Frame: The primary outcome will be assessed by ultrasound examination, 5 minutes after ending of the external cephalic version
|
The primary outcome of the study is to evaluate the successful rate of external cephalic version, after oral intake of two litres of water
|
The primary outcome will be assessed by ultrasound examination, 5 minutes after ending of the external cephalic version
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
amniotic fluid volume
Time Frame: 1 hour after the end of oral maternal hydration (2 litres)
|
We will assess the amniotic fluid index at recruitment (Baseline). 1 hour after ending of oral intake (2 litres of water), we will revalue the amniotic fluid volume
|
1 hour after the end of oral maternal hydration (2 litres)
|
|
type of birth
Time Frame: at birth
|
We will record if the woman will give birth by cesarean section or vaginal birth (spontaneous or operative)
|
at birth
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
type of breech presentation
Time Frame: Baseline
|
At recruitment we will assess the type of breech (frank breech, complete breech, footling or incomplete breech)
|
Baseline
|
|
placental localisation
Time Frame: baseline
|
At recruitment we will assess the placental localisation (anterior, posterior, right lateral, left lateral or fundal)
|
baseline
|
|
foetal back position
Time Frame: baseline
|
At recruitment we will evaluate the position of fetal back (anterior, posterior, right or left lateral)
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Antonietta A Scian, MD, San Gerardo Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
July 22, 2013
First Submitted That Met QC Criteria
July 26, 2013
First Posted (Estimate)
July 30, 2013
Study Record Updates
Last Update Posted (Estimate)
December 10, 2015
Last Update Submitted That Met QC Criteria
December 9, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- IDRI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.